 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
Screening & ADME Products & ServicesGE Healthcare continues to work with research, pharmaceutical and biotechnology industries to provide innovative, enabling tools to facilitate drug discovery. Our powerful portfolio of technologies spans key areas from target identification and validation through primary and secondary screening to lead profiling and pre-clinical development. The combination of integrated instrumentation, software, reagents, training and technical support enables customers to improve productivity and produce better hits faster. Our screening and ADME portfolio includes:
|
|
 |
Cell Factory
An outsourcing service that increases the capability and capacity of researchers who use cell-based assays in high throughput and high content screening. |
|
|
|
|
|
Fluorescent Screening Reagents
Cy dye fluorophores are robust, red-shifted dyes that are a popular choice for labeling in a variety of fluorescence-based applications in drug screening and assay development. |
|
|
|
|
Second Messenger EIAs
Our Biotrak™ range includes non-radiometric EIA kits, with novel lysis reagents to facilitate simple and rapid extraction of cAMP and cGMP. |
|
|
|
|
|
LEADseeker
High-throughput imaging systems with multiple detection modalities, including radiometric, luminescence, fluorescence intensity, TRF, FRET & FP for primary screening applications. |
|
|
|
|
Amersham Radiolabeling Service
High quality, organic compounds and biomolecules custom labeled with radioactive or stable isotopes for use in
pre-clinical and clinical in vivo
ADME studies and microdosing. |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Choose your destination
